Engaging Investor Conferences with ORIC Pharmaceuticals

ORIC Pharmaceuticals Participates in Key Investor Conferences

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) is actively engaging with the investment community through a series of upcoming conferences. As a clinical-stage oncology company, ORIC focuses on innovative treatments that target mechanisms behind therapeutic resistance, aiming to enhance patient outcomes across various cancer types. In September, ORIC's management will be participating in several high-profile investor conferences that provide an excellent platform for showcasing their progress and insights.

Citi's 2025 Biopharma Back to School Summit

One of the highlights includes participation in Citi's 2025 Biopharma Back to School Summit. ORIC's management will conduct a fireside chat on a dedicated panel allowing for in-depth discussions regarding their groundbreaking strategies. The chat is scheduled to take place on September 3, 2025, at 4:00 p.m. Eastern Time. This engagement provides a unique opportunity for investors to gain direct insights into ORIC's mission and impact.

2025 Wells Fargo Healthcare Conference

Following the Citi Summit, ORIC's team will also attend the 2025 Wells Fargo Healthcare Conference, participating in another pivotal fireside chat. Set for September 4, 2025, at 2:15 p.m. Eastern Time, this conference serves as an influential gathering for healthcare investors and industry players. ORIC’s presence highlights its commitment to transparency and investor relations.

Cantor Global Healthcare Conference 2025

On September 5, 2025, ORIC will take part in the Cantor Global Healthcare Conference, where management will once again engage in a fireside chat session at 8:35 a.m. Eastern Time. These discussions are crucial for fostering relationships with investors and are expected to provide insights into ORIC’s advancements in addressing cancer treatment challenges.

Morgan Stanley and Baird Global Healthcare Conferences

Moreover, the team will hold a series of one-on-one meetings during the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025. This setting allows for personalized interactions, facilitating deeper dialogues on investment strategies and company initiatives. Additionally, ORIC will participate in the Baird 2025 Global Healthcare Conference on September 10, 2025, with another fireside chat scheduled for 1:25 p.m. Eastern Time.

Webcast Availability and Replays

Interested investors and individuals unable to attend can access webcasts of these fireside chats through the investor section of ORIC’s official website. Replays will be available for a period of 90 days post-event, ensuring that all interested parties have an opportunity to stay informed about ORIC's activities and innovations.

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company devoted to enhancing the lives of patients by addressing therapeutic resistance in cancer. Its flagship product candidates, including ORIC-944 and enozertinib (also known as ORIC-114), are grounded in innovative science aimed at overcoming significant barriers in cancer treatment. ORIC-944 targets the polycomb repressive complex through its allosteric inhibition, particularly focusing on prostate cancer. In parallel, enozertinib offers targeted solutions for various genetically-defined cancers by selectively engaging with critical mutations.

With offices located in South San Francisco and San Diego, California, ORIC actively continues its mission to advance cancer therapies. For more detailed information, check out the ORIC Pharma website and consider following them on social media platforms like X and LinkedIn.

Frequently Asked Questions

What is ORIC Pharmaceuticals known for?

ORIC Pharmaceuticals specializes in developing innovative cancer treatments aimed at overcoming mechanisms of therapeutic resistance.

When will ORIC participate in the Citi Summit?

ORIC will participate in the Citi's 2025 Biopharma Back to School Summit on September 3, 2025.

How can I access the webcasts of ORIC’s conferences?

Webcasts of the fireside chats will be available through the investor section of the ORIC website, with replays for 90 days after each event.

What are ORIC’s main product candidates?

ORIC’s main product candidates are ORIC-944, aimed at treating prostate cancer, and enozertinib (ORIC-114), which focuses on various genetically defined cancers.

Where is ORIC Pharmaceuticals located?

ORIC Pharmaceuticals has offices in South San Francisco and San Diego, California.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.